Up to half of patients with proximal deep vein thrombosis (DVT) will develop post-thrombotic
syndrome (PTS) despite optimal anticoagulant therapy. PTS significantly impacts upon …

Objective To summarise and compare the efficacy and safety of various oral anticoagulants
(dabigatran, rivaroxaban, apixaban, and vitamin K antagonists) and antiplatelet agents …

BACKGROUND: Current standard therapy for patients with acute proximal deep vein
thrombosis (DVT) consists of anticoagulant therapy and graduated elastic compression …

OBJECTIVE: To assess each of the scoring systems used to diagnose and classify post-
thrombotic syndrome, a common chronic complication of deep vein thrombosis. The design …

Background Post‐thrombotic syndrome (PTS) is the most frequent complication of deep vein
thrombosis (DVT). Its diagnosis is based on clinical characteristics. However, symptoms and …

Venous thrombosis is a major public health problem associated with significant morbidity
and mortality and has a substantial impact on the quality of life. Over the years, it has …

Background Additional treatment with catheter-directed thrombolysis (CDT) has recently
been shown to reduce post-thrombotic syndrome (PTS). Objectives To estimate the cost …

Introduction Mechanisms contributing to the pathogenesis of chronic thromboembolic
pulmonary hypertension (CTEPH) are poorly understood. This disorder is characterized by …

Background Reported post-thrombotic syndrome (PTS) rates may be confounded by
including patients with a history of deep venous thrombosis (DVT) before the index event …

Post‐thrombotic syndrome (PTS) is the most common complication of deep vein thrombosis
(DVT). Current preventative strategies are limited to the daily wear of graduated …